Literature DB >> 8218369

Effects on cultured mammalian cells of myotoxin III, a phospholipase A2 isolated from Bothrops asper (terciopelo) venom.

E Butrón1, M Ghelestam, J M Gutiérrez.   

Abstract

Myotoxin III (MT-III), a myotoxic phospholipase A2 from Bothrops asper, was studied with respect to interactions with cultured mammalian cells and red blood cells. Tests of the cytopathogenic effect of MT-III on different cell lines indicated that rat skeletal muscle L6 myoblasts were more sensitive to the toxin than chinese hamster ovary cells, human lung fibroblasts, mouse adrenal tumour cells and rat intestinal epithelial cells. Specific plasma-membrane permeabilization was assayed as release of a cytosolic [3H]uridine nucleotide marker from toxin-treated L6 cells. A dose- and time-related membrane permeabilization was induced at 37 degrees C, but not at 0 degree C. A half-maximal effect was obtained after 20 min. 30 micrograms/ml MT-III induced 50% marker release in 1 h, and the effect was not reversed by post-incubation for up to 48 h in toxin-free medium. The membrane permeabilization in L6 cells did not seem to require cellular internalisation of the toxin. The catalytic site of the toxin was inactivated by alkylation with p-bromophenacyl bromide (BPB). This treatment abolished the toxin's specific PLA2 activity, as assayed in vitro, and reduced the PLA2 activity on the myoblast membrane by more than 95%, as measured by release of [14C]arachidonic acid from prelabelled cells. However, the membrane-permeabilizing effect (release of cytosolic marker) was reduced only by 70% upon modification with BPB. We also report that MT-III is not directly haemolytic, and one reason for this is the inability of the toxin to associate with the membranes of human or mouse erythrocytes. Taken together, the data suggest that MT-III at 37 degrees C binds to and penetrates the plasma membrane of cultured myoblasts, thereby inducing a rapid, direct and irreversible membrane permeabilization. This effect apparently depends in part on the PLA2 activity of the toxin and in part on a molecular region which is separate from the catalytic site.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218369     DOI: 10.1016/0167-4889(93)90080-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Screening of Bothrops snake venoms for L-amino acid oxidase activity.

Authors:  M Pessatti; J D Fontana; M F Furtado; M F Guimãraes; L R Zanette; W T Costa; M Baron
Journal:  Appl Biochem Biotechnol       Date:  1995       Impact factor: 2.926

2.  Cloning and identification of a complete cDNA coding for a bactericidal and antitumoral acidic phospholipase A2 from Bothrops jararacussu venom.

Authors:  Patrícia G Roberto; Simone Kashima; Silvana Marcussi; José O Pereira; Spartaco Astolfi-Filho; Auro Nomizo; José R Giglio; Marcos R M Fontes; Andreimar M Soares; Suzelei C França
Journal:  Protein J       Date:  2004-05       Impact factor: 2.371

3.  Role of enzymatic activity in muscle damage and cytotoxicity induced by Bothrops asper Asp49 phospholipase A2 myotoxins: are there additional effector mechanisms involved?

Authors:  Diana Mora-Obando; Cecilia Díaz; Yamileth Angulo; José María Gutiérrez; Bruno Lomonte
Journal:  PeerJ       Date:  2014-09-16       Impact factor: 2.984

Review 4.  Cytotoxicity of snake venom enzymatic toxins: phospholipase A2 and l-amino acid oxidase.

Authors:  Jia Jin Hiu; Michelle Khai Khun Yap
Journal:  Biochem Soc Trans       Date:  2020-04-29       Impact factor: 5.407

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.